Vasculitis & polymyalgia rheumatica

Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster

Arthritis Care Res (Hoboken)Published Prospective cohort study

Authors' conclusion

These results indicate that the decay of humoral immunity after primary vaccination is associated with prednisolone treatment, whereas the subsequent increase after booster vaccination, was not. Patients with low antibody concentrations following primary vaccination remained at an immunogenic disadvantage after a single booster vaccination.

Study context

Population
Patients with giant cell arteritis (GCA)/polymyalgia rheumatica (PMR) after primary SARS-CoV-2 vaccination and booster vaccinationpatients n = 24 at 6 months, n = 46 post booster
Exposure
GCA/PMR patients vs age-, sex-, and vaccine-matched controls
Outcome
Decay of antibody concentrations after primary vaccination and immunogenicity of SARS-CoV-2 booster vaccination
Follow-up
6 months after primary vaccination; 1 month after booster vaccination
Methodological detailsfollow-up study, age-, sex-, and vaccine-matched controls, multiple linear regression
  • Follow-up study
  • Age-, sex-, and vaccine-matched controls
  • Multiple linear regression

Main finding

As reported in the abstract

Antibody concentrations
  • Antibody concentrations decreased faster over time in GCA/PMR patients than in controls, associated with prednisolone treatment during primary vaccination
  • Post-booster antibody concentrations comparable between patients and controls

Observational data: associations, not effects.

Further findings

Predictors of post-booster antibody concentrations

Antibody concentrations post primary vaccination, but not treatment during booster vaccination, were predictive

Original publication

Humoral SARS–CoV‐2 Vaccine Responses in Patients With Giant Cell Arteritis and Polymyalgia Rheumatica: Decay After Primary Vaccination and Effects of the Booster. Arthritis Care Res (Hoboken). Published 4 August 2023. doi:10.1002/acr.25173

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.